Context Therapeutics Inc (CNTX)
1.39
-0.11
(-7.33%)
USD |
NASDAQ |
Nov 22, 16:00
1.32
-0.07
(-5.04%)
After-Hours: 20:00
Context Therapeutics Cash from Financing (Quarterly): -0.0446M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.0446M |
| June 30, 2024 | 94.80M |
| March 31, 2024 | |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2022 | -0.1021M |
| December 31, 2021 | 54.23M |
| September 30, 2021 | -0.8169M |
| June 30, 2021 | 1.948M |
| March 31, 2021 | 3.034M |
| December 31, 2020 | 0.35M |
| September 30, 2020 | 0.45M |
| June 30, 2020 | 0.3241M |
| March 31, 2020 | 0.025M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.8169M
Minimum
Sep 2021
94.80M
Maximum
Jun 2024
9.071M
Average
--
Median
Jun 2022
Cash from Financing (Quarterly) Benchmarks
| Collegium Pharmaceutical Inc | 149.03M |
| NovaBay Pharmaceuticals Inc | 2.089M |
| Palatin Technologies Inc | -0.127M |
| iBio Inc | -0.162M |
| Theriva Biologics Inc | 3.716M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.933M |
| Cash from Investing (Quarterly) | -14.76M |
| Free Cash Flow | -31.63M |
| Free Cash Flow Per Share (Quarterly) | -0.2074 |
| Free Cash Flow Yield | -54.39% |